BIOSYNTH shows leading edge chemiluminescence solutions at CPhI Japan 2018
Press Release | BIOSYNTH AG
APRIL 04, 2018
Staad, Switzerland: – Microbiology and organic fine biochemical CDMO and specialist supplier, BIOSYNTH AG will be showing its latest products at the leading Japanese pharma trade fair, CPhI Japan 2018, including its breakthrough AquaSpark™ chemiluminescence probes.
BIOSYNTH will exhibit at Booth Q27 in East Hall 1 of Tokyo’s Big Sight Exhibition Center. Products on display will include its newly introduced AquaSpark™ technology including innovative phosphatase and beta-galactosidase substrates.
“As an accomplished player and developer in the field of biochemicals for the diagnostics, pharmaceutical and chemical industries as well as food and environmental analysis, BIOSYNTH will be a significant presence at CPhI Japan” commented Business Development Director, Rolf Rolli.
“We believe our new developments in the field of chemiluminescence-based detection systems, AquaSpark™ probes and pro-luciferins, will be of particular interest to our stand visitors, particularly among diagnostics industries active in food, water and microbiology” said Mr. Rolli.
The BIOSYNTH stand will highlight the pioneering new dioxetanes of the AquaSpark™ product line, pro-luciferins, STAADIUM enzyme-activated inhibitors and RUG™ fluorogenic E.coliindicator as significant new additions to its portfolio of more than 100,000 products.
BIOSYNTH will also be showing its popular Aldol® chromogenic, fluorogenic substrates and newly available salt forms of Nicotinamide riboside.
Biosynth produces a number of APIs including Histamine x 2 HCl, 5-Aminolevulinic acid hydrochloride and Anagrelide HCl.
“We will be taking advantage of the huge visitor and exhibitor base in Tokyo to find new development projects and partners among small and industrial scale manufacturing organizations,” he explained.
The Swiss-based chemical supplier and manufacturing CDMO specializes in microbiology and organic fine chemicals in the field of bioluminescence and chemiluminescence probes, fluorescent probes, chromogenic substrates, enzyme substrates, indole derivatives and special chemicals. The company’s more than 100,000 products are widely used in microbiology, molecular biology, diagnostics, pharmaceutical industry, chemical industry, food and environmental testing.
Development projects, small and industrial scale manufacturing as well as global sourcing are all core competencies of the group, which is headquartered in Staad, Switzerland, its base for its production, sales, logistics, QA and QC, with operating subsidiaries in the USA (BIOSYNTH International, Inc, Itasca, IL) and in China (BIOSYNTH, Wuxi).
About CPhI Japan 2018
CPhI Japan is one of the family of high profile pharma trade shows created by UBM Live.
CPhI Japan 2018 is a three-day event opening April 18 at Tokyo’s Big Sight Exhibition Center. Apart from the main CPhI expo, there are four other zoned exhibitions: InnoPack, P-MEC (including LabWorld) for machinery and equipment, ICSE for outsourcing solutions, and BioPh for biotechnology.
The 2018 show is expected to be the biggest CPhI Japan event to date, attracting more than 20,000 visitors from some 55 countries. The event is organized by UBM Live with more information at: http://www.cphi.com/japan/home.
Tel: +41 71 858 20 20